https://www.selleckchem.com/pr....oducts/qnz-evp4593.h
Objectives We sought to characterise the outcomes of patients with haematological malignancy and SARS-CoV-2 infection in hospital in our regional network of 7 hospitals. Methods Consecutive hospitalised patients with haematological malignancy and SARS-CoV-2 infection were identified from 01/03/2020 to 06/05/2020. Outcomes were categorised as death, resolved, or ongoing. The primary outcome was preliminary case fatality rate (pCFR), defined as the number of cases resulting in death as a proportion of all diagnosed cases. Analysis was
Like
Comment
Share
